InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform
InMode (Nasdaq: INMD) has introduced IgniteRF, a revolutionary minimally invasive workstation featuring nine technologies for soft tissue contraction across multiple depths. This platform includes the BodyTite, FaceTite, Morpheus8, and the new QuantumRF family of products, offering a comprehensive suite of radiofrequency solutions for various aesthetic and surgical needs.
The QuantumRF technology deploys fractionated radiofrequency to maximal depths, with two lightweight cannulas: QuantumRF 10 for small, delicate areas and QuantumRF 25 for larger zones. This advancement allows physicians to deliver unprecedented results without invasive surgery. Radiofrequency technology has become the gold standard in skin contraction due to its effectiveness, safety, and minimally invasive nature, stimulating collagen production and promoting tissue remodeling for firmer, more youthful-looking skin.
InMode (Nasdaq: INMD) ha introdotto IgniteRF, una workstation rivoluzionaria minimamente invasiva che presenta nove tecnologie per la contrazione dei tessuti molli a diverse profondità. Questa piattaforma include BodyTite, FaceTite, Morpheus8 e la nuova famiglia di prodotti QuantumRF, offrendo un'ampia gamma di soluzioni a radiofrequenza per diverse necessità estetiche e chirurgiche.
La tecnologia QuantumRF utilizza radiofrequenza frazionata fino a profondità massimali, con due cannule leggere: QuantumRF 10 per aree piccole e delicate e QuantumRF 25 per zone più grandi. Questo progresso consente ai medici di ottenere risultati senza precedenti senza la necessità di un intervento chirurgico invasivo. La tecnologia a radiofrequenza è diventata lo standard d'oro per la contrazione della pelle grazie alla sua efficacia, sicurezza e natura minimamente invasiva, stimolando la produzione di collagene e promuovendo il rimodellamento dei tessuti per una pelle più fermo e dall'aspetto più giovane.
InMode (Nasdaq: INMD) ha presentado IgniteRF, una estación de trabajo revolucionaria mínimamente invasiva que cuenta con nueve tecnologías para la contracción de tejidos blandos a diferentes profundidades. Esta plataforma incluye BodyTite, FaceTite, Morpheus8 y la nueva familia de productos QuantumRF, ofreciendo un conjunto completo de soluciones de radiofrecuencia para diversas necesidades estéticas y quirúrgicas.
La tecnología QuantumRF despliega radiofrecuencia fraccionada a profundidades máximas, con dos cánulas ligeras: QuantumRF 10 para áreas pequeñas y delicadas y QuantumRF 25 para zonas más grandes. Este avance permite a los médicos lograr resultados sin precedentes sin cirugía invasiva. La tecnología de radiofrecuencia se ha convertido en el estándar de oro en la contracción de la piel debido a su efectividad, seguridad y naturaleza mínimamente invasiva, estimulando la producción de colágeno y promoviendo la remodelación de los tejidos para una piel más firme y con un aspecto más joven.
InMode (나스닥: INMD)는 여러 깊이에서 연조직 수축을 위한 아홉 가지 기술이 포함된 혁신적인 최소 침습 작업대인 IgniteRF를 소개했습니다. 이 플랫폼은 BodyTite, FaceTite, Morpheus8 및 새로운 QuantumRF 제품군을 포함하여 다양한 미용 및 외과적 요구를 위한 포괄적인 라디오 주파수 솔루션을 제공합니다.
QuantumRF 기술은 최대 깊이까지 분수 라디오 주파수를 배치하며, 두 개의 가벼운 캐뉼라를 사용합니다: 작은 섬세한 부위에 적합한 QuantumRF 10과 더 큰 영역에 적합한 QuantumRF 25입니다. 이 발전은 의사들이 침습적인 수술 없이 전례 없는 결과를 제공할 수 있게 해줍니다. 라디오 주파수 기술은 효과적이고 안전하며 최소한의 침습성 때문에 피부 수축의 금본위제가 되었으며, 콜라겐 생성을 자극하고 조직 재구성을 촉진하여 더 탄탄하고 젊어 보이는 피부로 만들어줍니다.
InMode (Nasdaq: INMD) a lancé IgniteRF, un poste de travail révolutionnaire minimalement invasif qui comprend neuf technologies pour la contraction des tissus mous à différentes profondeurs. Cette plateforme inclut BodyTite, FaceTite, Morpheus8 et la nouvelle famille de produits QuantumRF, proposant un ensemble complet de solutions de radiofréquence pour divers besoins esthétiques et chirurgicaux.
La technologie QuantumRF utilise une radiofréquence fractionnée jusqu'à des profondeurs maximales, avec deux canules légères : QuantumRF 10 pour les petites zones délicates et QuantumRF 25 pour les zones plus grandes. Cette avancée permet aux médecins d'obtenir des résultats sans précédent sans chirurgie invasive. La technologie de radiofréquence est devenue la norme d'or dans la contraction de la peau grâce à son efficacité, sa sécurité et son caractère minimalement invasif, stimulant la production de collagène et favorisant le remodelage des tissus pour une peau plus ferme et au vieillissement plus jeune.
InMode (Nasdaq: INMD) hat IgniteRF eingeführt, eine revolutionäre minimalinvasive Arbeitsstation, die neun Technologien zur Kontraktion von Weichgewebe auf verschiedenen Tiefen bietet. Diese Plattform beinhaltet BodyTite, FaceTite, Morpheus8 und die neue QuantumRF Produktfamilie, die eine umfassende Palette von Radiofrequenzlösungen für verschiedene ästhetische und chirurgische Anforderungen bereitstellt.
Die QuantumRF Technologie setzt fraktionierte Radiofrequenz bis zu maximalen Tiefen ein, mit zwei leichten Kanülen: QuantumRF 10 für kleine, empfindliche Bereiche und QuantumRF 25 für größere Zonen. Diese Weiterentwicklung ermöglicht es Ärzten, bislang unerreichbare Ergebnisse ohne invasive Chirurgie zu erzielen. Die Radiofrequenztechnologie hat sich aufgrund ihrer Effektivität, Sicherheit und minimalinvasiven Natur zum Goldstandard in der Hautkontraktion entwickelt, indem sie die Kollagenproduktion anregt und die Geweberemodellierung fördert, um eine straffere und jugendlicher aussehende Haut zu erreichen.
- Introduction of IgniteRF, a comprehensive minimally invasive workstation with nine technologies
- Launch of QuantumRF, an advanced fractionated radiofrequency technology for maximal depth treatments
- Expansion of product portfolio with BodyTite, FaceTite, Morpheus8, and QuantumRF family
- QuantumRF offers up to seven times more efficiency than other devices, according to Dr. Alfredo Hoyos
- None.
InMode's introduction of IgniteRF represents a significant advancement in the aesthetic medical technology sector. This platform consolidates nine technologies for soft tissue contraction, potentially streamlining treatment options and improving efficiency for practitioners. The inclusion of QuantumRF, a new minimally invasive technology, is particularly noteworthy.
Key points to consider:
- The IgniteRF platform's comprehensive approach could strengthen InMode's market position, potentially driving increased adoption among aesthetic professionals.
- QuantumRF's fractionated radiofrequency technology, reaching maximal depths, may offer a competitive edge in the rapidly growing minimally invasive aesthetics market.
- The versatility of QuantumRF 10 and QuantumRF 25 cannulas allows for treatment of various body areas, potentially expanding the addressable market.
From an investor's perspective, this innovation could translate to increased revenue streams and market share for InMode. However, it's important to monitor adoption rates and clinical outcomes to gauge the long-term impact on the company's financial performance.
The introduction of IgniteRF by InMode represents a significant leap forward in minimally invasive aesthetic treatments. As a plastic surgeon, I can attest to the growing demand for less invasive procedures that offer substantial results with minimal downtime.
The QuantumRF technology is particularly intriguing. Its ability to deliver fractionated radiofrequency to maximal depths without the need for temperature build-up is a game-changer. This could potentially reduce procedure time and improve patient comfort, two critical factors in the competitive aesthetics market.
Dr. Alfredo Hoyos' endorsement carries significant weight in the field. His success with over 100 QuantumRF procedures and his claim of up to
For investors, this technology could position InMode as a leader in the rapidly growing 'tweakment' market - procedures that offer noticeable results without the downtime of traditional surgery. However, it's important to monitor adoption rates among practitioners and patient satisfaction to gauge the long-term success of this platform.
The IgniteRF platform, alongside the BodyTite, FaceTite, Morpheus8, and now QuantumRF family of products offers a comprehensive suite of radiofrequency solutions for various aesthetic and surgical needs. QuantumRF is a new, advanced minimally invasive technology which deploys fractionated radiofrequency to maximal depths. The two lightweight and versatile cannulas, QuantumRF 10 for small, more delicate treatment zones and QuantumRF 25 for larger treatment zones enable physicians to deliver unprecedented results without invasive surgery.
Radiofrequency (RF) technology has emerged as the gold standard in skin contraction within the aesthetics industry, due to its effectiveness, safety, and minimally or non-invasive nature. RF treatments heat the deeper layers of the skin, stimulating collagen production and promoting tissue remodeling. This process results in contracted, firmer skin and a more youthful appearance. One of the primary reasons RF is favored in aesthetics is its ability to deliver consistent and noticeable results with minimal discomfort and downtime. Unlike more surgical procedures, RF treatments do not require incisions or extensive surgery and recovery periods.
"IgniteRF marks a significant milestone for InMode, with continued innovation to make our best in-class technology faster, smarter, and even more exceptional results," says Dr. Michael Kreindel, CTO and Co-founder of InMode.
Dr. Alfredo Hoyos, a board-certified plastic surgeon from
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Press Contact:
Behrman Cesa Communications
inmode@behrmancesa.com
Investor Contact:
MS-IR LLC
Miri Segal – Scharia
ir@inmodemd.com
Tel: 917-607-8654
Photo - https://mma.prnewswire.com/media/2472167/AH_QuantumRF_Abs_Female.jpg
Photo - https://mma.prnewswire.com/media/2472168/AH_QuantumRF_Abs_Male.jpg
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-introduces-igniterf-the-complete-minimally-invasive-soft-tissue-contraction-platform-302210523.html
SOURCE InMode LTD
FAQ
What is IgniteRF and how does it benefit InMode (INMD)?
How does QuantumRF technology work in InMode's (INMD) new IgniteRF platform?
What advantages does InMode's (INMD) QuantumRF offer over other devices?
How might the introduction of IgniteRF impact InMode's (INMD) market position?
